Of note, Simon and colleagues reported that increased expression of ERCC1 is an independent predictor of improved survival in resected patients with NSCLC and that this may be secondary to a decreased accumulation of genomic aberrations as a result of efficient DNA-damage repair system [36]. Here, ERCC1 is linked to non-small cell lung carcinoma.